Core Viewpoint - Kexing Biopharmaceutical Co., Ltd. has successfully passed the AEO advanced certification audit, enhancing its credibility and operational efficiency in international trade, particularly in the high-end biopharmaceutical market [1][3]. Group 1: Company Overview - Kexing Biopharmaceutical is an innovative biopharmaceutical company with over 20 years of international experience, selling products in more than 70 countries and regions [1]. - The company is currently exporting erythropoietin injection worth 12.13 million yuan to Brazil, highlighting its active role in the global market [1]. Group 2: Challenges and Solutions - The company faces stringent requirements for cold chain logistics, needing to maintain a temperature of 2-8°C during transport, where even an additional hour in transit increases logistics costs and risks of product efficacy [1]. - The local customs authority has recognized the company's needs and has taken proactive measures to support it, including forming a specialized team to assist with AEO certification [3]. Group 3: Benefits of AEO Certification - Following AEO certification, the company has experienced a significant reduction in inspection rates and expedited customs clearance, reducing the transport time for shipments to Brazil from 7 days to approximately 5 days [3]. - The AEO certification has provided tangible benefits, including lower logistics costs, enhanced product competitiveness, and improved patient medication safety [3]. Group 4: Industry Impact - The AEO certification is seen as a key driver for high-quality foreign trade development, with the local customs authority implementing a comprehensive support system for businesses [3]. - In the first half of the year, Jinan added three new AEO certified enterprises, bringing the total to 27, which collectively accounted for over 40% of the city's total import and export value, underscoring their importance in stabilizing and enhancing the local foreign trade landscape [3].
AEO认证助力生物药出海抢出“黄金48小时”